Jundishapur Journal of Microbiology

Published by: Kowsar

Antimicrobial Susceptibility Pattern and Prevalence of Extended-Spectrum β-Lactamase Genotypes among Clinical Isolates of Acinetobacter baumanii in Tabriz, North-West of Iran

Shiva Ahdi Khosroshahi 1 , Safar Farajnia 2 , * , Fatemeh Azhari 3 , Mohammad Kazem Hosseini 3 , Farzad Khanipour 4 , Hadi Farajnia 4 and Behrooz Naghili 5
Authors Information
1 Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
2 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
3 Istanbul University, Faculty of Sciences, Molecular Biology and Genetics, Istanbul, Turkey
4 Tuberculosis and Lung Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
5 Infectious and tropical Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: June 2017, 10 (6); e13368
  • Published Online: May 29, 2017
  • Article Type: Research Article
  • Received: October 1, 2016
  • Revised: February 28, 2017
  • Accepted: March 18, 2017
  • DOI: 10.5812/jjm.13368

To Cite: Ahdi Khosroshahi S, Farajnia S, Azhari F, Hosseini M K, Khanipour F, et al. Antimicrobial Susceptibility Pattern and Prevalence of Extended-Spectrum β-Lactamase Genotypes among Clinical Isolates of Acinetobacter baumanii in Tabriz, North-West of Iran, Jundishapur J Microbiol. 2017 ; 10(6):e13368. doi: 10.5812/jjm.13368.

Copyright © 2017, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996; 9(2): 148-65[PubMed]
  • 2. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008; 21(3): 538-82[DOI][PubMed]
  • 3. Boroumand MA, Akhyani H, Sheikhvatan M, Yazdi SH, Saboorian R, Hashemi SH, et al. Evaluation of antimicrobial resistance of Acinetobacter baumannii to Imipenem, Ciporofloxacin and Ceftazidime using E Test. Iran J Public Health. 2009; 38(2): 130-3
  • 4. Falagas ME, Bliziotis IA, Siempos ,I. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care. 2006; 10(2)[DOI][PubMed]
  • 5. Meric M, Kasap M, Gacar G, Budak F, Dundar D, Kolayli F, et al. Emergence and spread of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital in Turkey. FEMS Microbiol Lett. 2008; 282(2): 214-8[DOI][PubMed]
  • 6. Shi ZY, Liu PY, Lau Y, Lin Y, Hu BS, Shir JM. Antimicrobial susceptibility of clinical isolates of Acinetobacter baumannii. Diagn Microbiol Infect Dis. 1996; 24(2): 81-5[PubMed]
  • 7. Shaikh S, Fatima J, Shakil S, Rizvi SM, Kamal MA. Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J Biol Sci. 2015; 22(1): 90-101[DOI][PubMed]
  • 8. Ribera A, Vila J, Fernandez-Cuenca F, Martinez-Martinez L, Pascual A, Beceiro A, et al. Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitals. Antimicrob Agents Chemother. 2004; 48(1): 364-5[PubMed]
  • 9. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005; 18(4): 657-86[DOI][PubMed]
  • 10. Wilke MS, Lovering AL, Strynadka NC. Beta-lactam antibiotic resistance: a current structural perspective. Curr Opin Microbiol. 2005; 8(5): 525-33[DOI][PubMed]
  • 11. Sturenburg E, Mack D. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect. 2003; 47(4): 273-95[PubMed]
  • 12. Bali EB, Accedil L, Sultan N. Phenotypic and molecular characterization of SHV, TEM, CTX-M and extended-spectrum-lactamase produced by Escherichia coli, Acinobacter baumannii and Klebsiella isolates in a Turkish hospital. Afr J Microbiol Res. 2010; 4(8): 650-4
  • 13. Huang LY, Chen TL, Lu PL, Tsai CA, Cho WL, Chang FY, et al. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Clin Microbiol Infect. 2008; 14(11): 1010-9[DOI][PubMed]
  • 14. Jain A, Mondal R. TEM & SHV genes in extended spectrum beta-lactamase producing Klebsiella species beta their antimicrobial resistance pattern. Indian J Med Res. 2008; 128(6): 759-64[PubMed]
  • 15. Bell SM, Gatus BJ, Pham JN, Rafferty DL. Antibiotic susceptibility testing by the CDS method. A concise laboratory manual. NSW: The antibiotic reference laboratory, South Eastern Area Laboratory Services. 1999;
  • 16. Hall G. Textbook of diagnostic microbiology. 2007; : 564-84
  • 17. Wayne P. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing. 2007;
  • 18. Nagano N, Nagano Y, Cordevant C, Shibata N, Arakawa Y. Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. J Clin Microbiol. 2004; 42(9): 3978-84[DOI][PubMed]
  • 19. Yousefi S, Farajnia S, Nahaei MR, Akhi MT, Ghotaslou R, Soroush MH, et al. Detection of metallo-beta-lactamase-encoding genes among clinical isolates of Pseudomonas aeruginosa in northwest of Iran. Diagn Microbiol Infect Dis. 2010; 68(3): 322-5[DOI][PubMed]
  • 20. Brown S, Amyes S. OXA (beta)-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother. 2006; 57(1): 1-3[DOI][PubMed]
  • 21. Livermore DM. The threat from the pink corner. Ann Med. 2003; 35(4): 226-34[PubMed]
  • 22. Tognim MC, Andrade SS, Silbert S, Gales AC, Jones RN, Sader HS. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program. Int J Infect Dis. 2004; 8(5): 284-91[DOI][PubMed]
  • 23. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008; 358(12): 1271-81[DOI][PubMed]
  • 24. Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N. Isolation and genetic characterization of metallo-beta-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol. 2011; 3(2): 68-74[PubMed]
  • 25. Mohajeri P, Farahani A, Feizabadi MM, Ketabi H, Abiri R, Najafi F. Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran. Iran J Microbiol. 2013; 5(3): 195-202[PubMed]
  • 26. Sinha M, Srinivasa H, Macaden R. Antibiotic resistance profile & extended spectrum beta-lactamase (ESBL) production in Acinetobacter species. Indian J Med Res. 2007; 126(1): 63-7[PubMed]
  • 27. Vahaboglu H, Ozturk R, Aygun G, Coskunkan F, Yaman A, Kaygusuz A. Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother. 1997; 41(10): 2265-9[PubMed]
  • 28. Zhao SY, Jiang DY, Xu PC, Zhang YK, Shi HF, Cao HL, et al. An investigation of drug-resistant Acinetobacter baumannii infections in a comprehensive hospital of East China. Ann Clin Microbiol Antimicrob. 2015; 14: 7[DOI][PubMed]
  • 29. Celenza G, Pellegrini C, Caccamo M, Segatore B, Amicosante G, Perilli M. Spread of bla(CTX-M-type) and bla(PER-2) beta-lactamase genes in clinical isolates from Bolivian hospitals. J Antimicrob Chemother. 2006; 57(5): 975-8[DOI][PubMed]
  • 30. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995; 39(6): 1211-33[PubMed]
  • 31. Jacoby G, Bush K. ß-Lactamase classification and amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant enzymes. 2014;
  • 32. Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob Agents Chemother. 2010; 54(1): 24-38[DOI][PubMed]
  • 33. Farajnia S, Azhari F, Alikhani MY, Hosseini MK, Peymani A, Sohrabi N. Prevalence of PER and VEB Type Extended Spectrum Betalactamases among Multidrug Resistant Acinetobacter baumannii Isolates in North-West of Iran. Iran J Basic Med Sci. 2013; 16(6): 751-5[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments